Basic MaterialsMonday, February 23, 2026

Rep. Michael McCaul Buys Intl Flavors (NYSE:IFF) Stock

Representative Michael McCaul (Republican) disclosed the purchase of $100,001 - $250,000 of International Flavors & Fragrances Inc. (NYSE:IFF) in a filing made on February 12th, 2026. The transaction, dated January 13th, 2026, was reported as a purchase by his spouse.

SR

Staff Reporter

Published Monday, February 23, 2026

Rep. Michael McCaul Buys Intl Flavors (NYSE:IFF) Stock

Rep. Michael McCaul Buys Intl Flavors (NYSE:IFF) Stock

Representative Michael McCaul (Republican) disclosed the purchase of $100,001 - $250,000 of International Flavors & Fragrances Inc. (NYSE:IFF) in a filing made on February 12th, 2026. The transaction, dated January 13th, 2026, was reported as a purchase by his spouse.

Michael McCaul's Recent Trades

  • 11/28/2025: Bought $1,001 - $15,000 of SAP stock
  • 11/26/2025: Sold $15,001 - $50,000 of FCFS stock
  • 11/24/2025: Sold $100,001 - $250,000 of G stock
  • 11/24/2025: Sold $1,001 - $15,000 of AER stock
  • 11/20/2025: Bought $15,001 - $50,000 of MSA stock
  • 11/19/2025: Bought $15,001 - $50,000 of ATR stock
  • 11/19/2025: Bought $15,001 - $50,000 of VVV stock
  • 11/19/2025: Sold $50,001 - $100,000 of SSD stock
  • 11/19/2025: Sold $1,001 - $15,000 of ASML stock
  • 11/19/2025: Sold $1,001 - $15,000 of GOOGL stock

IFF Stock Performance

Shares of IFF opened at $81.77 on Monday, down 0.28%. The 50-day moving average is $70.87 and the 200-day moving average is $69.60. The 52-week low is $59.14 and the 52-week high is $84.45.

Since the transaction date (January 13th, 2026), IFF shares have risen 17.53%, opening at $69.25 on the transaction date. The stock rose 2.32% in the first week and 5.72% over two weeks, and 17.69% over one month.

IFF reported FY 2025 revenue of $10.89 billion and net income of -$374,000,000, producing EPS of -$1.46. Debt-to-equity was 0.42, the current ratio was 1.42 and the quick ratio was 0.85. Market capitalization was $20.84 billion, the trailing P/E was -59.87 and beta was 1.04. Return on equity was -2.49% and net profit margin was -3.20%. Year-over-year revenue change from FY 2024 to FY 2025 was -5.17%. Analysts' average full-year EPS forecast (2028) was $5.30.

Key Stories Impacting IFF

  • (Neutral) Q4 / Full-Year 2025 results — IFF reported mixed Q4 2025 results on Feb. 12, 2026 (revenue beat but EPS missed; management gave 2026 EBITDA guidance and commentary on margins).
  • (Positive) Launched formal sale process for the Food Ingredients segment — analysts and trade press reported IFF moved to a formal sale/evaluation process for its Food Ingredients business (reported Feb. 12, 2026).
  • (Neutral) Agreed to divest soy crush, soy protein concentrate and lecithin business to Bunge — IFF announced a definitive agreement on Aug. 5, 2025 for the sale of those assets.
  • (Positive) $500 million share-repurchase authorization — IFF announced a $500M buyback program disclosed with Q2 2025 results on Aug. 5, 2025.
  • (Neutral) Continued portfolio reshaping and margin commentary — trade press noted IFF's 2025 portfolio moves, margin improvement and focus on higher-value businesses (early Feb. 2026).
  • (Positive) Analyst action: Morgan Stanley note (Feb. 13, 2026) — Morgan Stanley kept an Overweight stance and raised its IFF price target following the Q4 report.
  • (Neutral) Notable short-term stock moves around the earnings release — IFF shares jumped on Feb. 12, 2026 (a ~5.9% gain) amid the earnings release and follow-up analyst commentary.

Analyst Ratings for IFF

Mizuho reiterated an 'Outperform' rating on Feb. 17, 2026. Barclays reiterated an 'Overweight' rating on Feb. 17, 2026. Citigroup reiterated a 'Buy' rating on Feb. 13, 2026. Wells Fargo reiterated an 'Overweight' rating on Feb. 13, 2026. Oppenheimer upgraded to an 'Outperform' rating on Feb. 13, 2026.

Presently, 206 analysts have rated IFF with a buy recommendation, 103 have issued a hold, and 24 have given a sell rating. The average rating is 'Moderate Buy' with an average price target of $90.38.

Institutional Investors Weigh In On IFF

DODGE & COX holds 36,401,042 shares valued at $2.96 billion. VANGUARD GROUP INC holds 30,354,754 shares valued at $2.47 billion. FREEMONT CAPITAL PTE LTD holds 25,356,381 shares valued at $2.06 billion. BLACKROCK, INC. holds 22,034,266 shares valued at $1.79 billion. STATE STREET CORP holds 11,092,368 shares valued at $902.81 million. Currently, 67.15% of the stock is owned by institutional investors.

About Michael McCaul

Representative Michael McCaul is a Republican member of the U.S. House representing Texas's 10th congressional district. He has served in the House since 2005 and is 64 years old. McCaul's disclosures list this transaction as a purchase by his spouse.

About IFF

International Flavors & Fragrances Inc. is a Chemicals - Specialty company that manufactures and sells flavor, fragrance and cosmetic active ingredients across Nourish, Scent, Health & Biosciences and Pharma Solutions segments. The company is headquartered in New York City, was founded in 1833 and completed its IPO in 1974. Jon Erik Fyrwald is listed as CEO.

Filed under

Insider TradingCongressional DisclosureIFFBasic MaterialsNYSEBuyHouse

See What Politicians Are Trading Before the Market Moves

Download the app and get real-time alerts on congressional trades.

Download on the App StoreGet it on Google Play

Related Articles

More stories you might find relevant